Taylor Ian has filed 15 insider transactions across 1 company since February 2023.
Most recent transaction: a sale of 7356 shares of ARVINAS, INC. ($ARVN) on February 24, 2025.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2025 | ARVINAS, INC. | $ARVN | Taylor Ian | President, R&D | S | Common Stock | 7356 | $16.75 | 160,785.0000 | 68,800,000 | 4.37% | 0.01% |
| Feb. 24, 2025 | ARVINAS, INC. | $ARVN | Taylor Ian | President, R&D | S | Common Stock | 1664 | $16.55 | 159,121.0000 | 68,800,000 | 1.03% | 0.00% |
| Feb. 13, 2025 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | A | Common Stock | 20619 | $0.00 | 168,141.0000 | 68,800,000 | 13.98% | 0.03% |
| Feb. 13, 2025 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | A | Stock Option (right to buy) | 31483 | $0.00 | 31,483.0000 | 68,800,000 | 9999.99% | 0.05% |
| Feb. 23, 2024 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | A | Common Stock | 39250 | $0.00 | 149,223.0000 | 68,000,000 | 35.69% | 0.06% |
| Feb. 23, 2024 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | S | Common Stock | 1701 | $47.05 | 147,522.0000 | 68,000,000 | 1.14% | 0.00% |
| Feb. 23, 2024 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | A | Stock Option (right to buy) | 58100 | $0.00 | 58,100.0000 | 68,000,000 | 9999.99% | 0.09% |
| Jan. 4, 2024 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | M | Common Stock | 8252 | $16.00 | 109,973.0000 | 68,000,000 | 8.11% | 0.01% |
| Jan. 4, 2024 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | M | Stock Option (right to buy) | 0 | $0.00 | 10,519.0000 | 68,000,000 | 0.00% | 0.00% |
| Jan. 4, 2024 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | M | Stock Option (right to buy) | 0 | $0.00 | 2,065.0000 | 68,000,000 | 0.00% | 0.00% |
| March 1, 2023 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | M | Common Stock | 2685 | $0.00 | 102,772.0000 | 53,200,000 | 2.68% | 0.01% |
| March 1, 2023 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | S | Common Stock | 1051 | $29.53 | 101,721.0000 | 53,200,000 | 1.02% | 0.00% |
| March 1, 2023 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | M | Restricted Stock Units | 2685 | $0.00 | 0.0000 | 53,200,000 | 100.00% | 0.01% |
| Feb. 22, 2023 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | A | Common Stock | 19125 | $0.00 | 100,087.0000 | 53,200,000 | 23.62% | 0.04% |
| Feb. 22, 2023 | ARVINAS, INC. | $ARVN | Taylor Ian | Chief Scientific Officer | A | Stock Option (right to buy) | 57450 | $0.00 | 57,450.0000 | 53,200,000 | 9999.99% | 0.11% |